PRESENTATIONS AND SEMINARS

PRESENTATIONS AND SEMINARS (2011-PRESENT)

 

2015

Ole Tietz, James P.K. Dzandzi, Atul Bhardwaj, John F. Valliant, Frank Wuest, “Synthesis of a novel 125I-labelled radiotracer for molecular imaging of cyclooxygenase-2 (COX-2)”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.

  1. Yazdani, S. Czorny, J.F. Valliant, “Synthesis and Evaluation of [2+1] Re(I)/99mTc(I) Complexes as Isostructural Luminescent Turn-on and Nuclear Imaging Probes”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.

Patricia Edem, Nancy Janzen, Silvia A. Albu, Denis R. Beckford-Vera, John F. Valliant, “Evaluation of Bioorthogonal Reactive Pairs for Cathepsin B Imaging in Metastatic Cancer”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.

  1. Al-Karmi, S. Albu, N. Janzen, A. Capretta, J.F. Valliant, “A 18F Labeling Strategy for Near Infrared Fluorophores: Multi-Modal Probes for Reactive Oxygen Species”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.
  2. Slikboer, T.S. Pitchumony, J.F. Valliant, “Imidazole Fused Phenanthroline (PIP) Ligands for the Preparation of Multimodal Re(I) and 99mTc(I) Probes”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.
  3. Ahmad, A. Zlitni, N. Janzen, S. Czorny, L.C. Francesconi, B. Zeglis, J.F. Valliant, “Tetrazine Functionalized [M(CO)3]+ (M= 99mTc, Re) Tridentate Chelate Complexes for Molecular Imaging Using Bio-Orthogonal Chemistry”, 21st International Symposium on Radiopharmaceutical Sciences, Columbia, Missouri, May 26-31, 2015.

2014

  1. Zlitni, J.F. Valliant, F.S. Foster, “Catching Bubbles. A new approach for targeting ultrasound contrast agents using bioorthogonal chemistry”, World Molecular Imaging Congress, Seoul, Korea, Sept 17-20, 2014.
  2. Zlitni, A.R. Genady, N. Janzen, and J.F. Valliant, “The preparation and preclinical evaluation of 99mTc-labeled microbubbles for bimodal ultrasound and SPECT imaging”, Terrachem, Bressanone, Italy, Sept 11, 2014.
  3. Yazdani, T.S. Pitchumony, L. Banevicius, S. Czorny, and J.F. Valliant, “Imidazole Stabilized [2+1] Re(I)/99mTc(I) Complexes as Isostructural Nuclear and Optical Probes”, Terrachem, Bressanone, Italy, Sept 11, 2014.
  4. Schaffer, F. Bénard, K. Buckley, A. Celler, S. Foster, M. Kovacs, F.S. Prato, T.J. Ruth, and J.F. Valliant, “Technical Progress and Preliminary Cost Analysis for the Direct Production of 99mTc”, 2014 Topical Meeting on Molybdenum-99 Technological Development, Washington D.C., USA, June 24-27, 2014.

2013

J.P. Dzandzi, D.R. Beckford Vera, J.F. Valliant, “A hybrid solution-solid-phase kit-type radioiodination and purification platform”, Society of Nuclear Medicine Annual Meeting, British Columbia, Canada, June 11, 2013.

  1. Zlitni, A.R. Genady, J.F. Valliant, “The development and evaluation of a multimodality imaging probe for US, SPECT and optical imaging”, Society of Nuclear Medicine Annual Meeting, British Columbia, Canada, June 11, 2013.

2012

S.M. Rathmann, A. Darwish, N. Janzen, J.F. Valliant, “Triazole Appending Agent – A Novel Synthon for the Development of Targeted Iodine Based Molecular Imaging Probes”, Imaging Applications in Prostate Cancer, London, Canada, Poster, November 16, 2012.

  1. Zlitni, A.R. Genady, J.F. Valliant, “The Preparation and Evaluation of Targeted Multimodality Imaging Probes for Prostate Cancer”, Imaging Applications in Prostate Cancer, London, Canada, Poster, November 16, 2012.

Laura Banevicius, Afaf Genady, John Valliant, “Evaluation of a multi-purpose molecular imaging probe and therapeutic agent for detection and treatment of prostate cancer”, Imaging Applications in Prostate Cancer, London, Canada, Poster, November 16, 2012.

Aimen Zlitni, Afaf R. Genady, John F. Valliant, “Developing a Platform for The Use of Microbubbles for Molecular, Optical and Ultrasound”, Imaging Network Ontario Symposium, Toronto, Canada, February 14, 2012.

Patricia E. Edem, John F. Valliant, “Evaluation of Cathepsin B Targeted Molecular Imaging Agents For the Detection of Aggressive Breast Cancers”, Imaging Network Ontario Symposium, Toronto, Canada February 2012.

2011

  1. Weaver, R. Simms, K. Stephenson, J.F. Valliant, “Droplet Microreactors: A New Platform for Radiopharmaceuticals”, Society of Nuclear Medicine, San Antonio, USA, June 2011.